Paper · 31533396
The Implication of Cytogenetic Alterations in Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm Identified by Fluorescence In Situ Hybridization and Their Potential Diagnostic Utility.
Lim CS and 7 others. Gut Liver, 2020. Cited by 8 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Implication of Cytogenetic Alterations in Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm Identified by Fluorescence In Situ Hybridization and Their Potential Diagnostic Utility. Papers, record 31533396. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31533396
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
The Implication of Cytogenetic Alterations in Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm Identified by Fluorescence In Situ Hybridization and Their Potential Diagnostic Utility.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Pancreatic Ductal | Major topic |
| Pancreatic Neoplasms | Major topic |
| Aged | |
| Female | |
| Humans | |
| In Situ Hybridization, Fluorescence | |
| Male | |
| Middle Aged | |
| Pancreatic Ducts |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 32,655,017 | Does the Cytogenetic Analysis Using Fluorescence In Situ Hybridization Improve the Preoperative Diagnostic Accuracy of Pancreatic Ductal Adenocarcinoma? | https://conductscience.org/library/papers/32655017 |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17,889,705 | Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes. | Cancer Genet Cytogenet | 2007 | https://conductscience.org/library/papers/17889705 | PubMed |
| 2 | 12,459,728 | Pancreatic cancer biology and genetics. | Nat Rev Cancer | 2002 | https://conductscience.org/library/papers/12459728 | PubMed |
| 3 | 19,525,336 | Statistical treatment of fluorescence in situ hybridization validation data to generate normal reference ranges using Excel functions. | J Mol Diagn | 2009 | https://conductscience.org/library/papers/19525336 | PubMed |
| 4 | 11,337,365 | Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. | Am J Pathol | 2001 | https://conductscience.org/library/papers/11337365 | PubMed |
| 5 | 26,491,091 | Comparison of Ultrasound-Guided Core Needle Biopsy and Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Solid Pancreatic Lesions. | J Ultrasound Med | 2015 | https://conductscience.org/library/papers/26491091 | PubMed |
| 6 | 15,330,900 | A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. | Am J Gastroenterol | 2004 | https://conductscience.org/library/papers/15330900 | PubMed |
| 7 | 19,232,347 | A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures. | Gastroenterology | 2009 | https://conductscience.org/library/papers/19232347 | PubMed |
| 8 | 19,247,032 | Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma. | Ann Surg | 2009 | https://conductscience.org/library/papers/19247032 | PubMed |
| 9 | 25,517,961 | Locus/chromosome aberrations in intraductal papillary mucinous neoplasms analyzed by fluorescence in situ hybridization. | Am J Surg Pathol | 2015 | https://conductscience.org/library/papers/25517961 | PubMed |
| 10 | 10,980,115 | Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. | Am J Pathol | 2000 | https://conductscience.org/library/papers/10980115 | PubMed |
1 to 10 of 30
See all 30 referencesCited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,279,399 | Maspin Modulates Malignant Phenotypes Depending on Subcellular Localization in Pancreatic Ductal Adenocarcinoma Cell Lines. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42279399 | PubMed |
| 42,115,262 | Integrative multi-omics analysis identifies ATAD1 as a potential regulator of metastasis in pancreatic cancer. | Sci Rep | 2026 | https://conductscience.org/library/papers/42115262 | PubMed |
| 36,831,465 | Are Aspects of Integrative Concepts Helpful to Improve Pancreatic Cancer Therapy? | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36831465 | PubMed |
| 36,289,850 | Effects of the Exposure of Human Non-Tumour Cells to Sera of Pancreatic Cancer Patients. | Biomedicines | 2022 | https://conductscience.org/library/papers/36289850 | PubMed |
| 35,625,579 | Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool. | Biomolecules | 2022 | https://conductscience.org/library/papers/35625579 | PubMed |
| 32,655,017 | Does the Cytogenetic Analysis Using Fluorescence In Situ Hybridization Improve the Preoperative Diagnostic Accuracy of Pancreatic Ductal Adenocarcinoma? | Gut Liver | 2020 | https://conductscience.org/library/papers/32655017 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDKN2A | 1,029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| CEACAM3 | 1,084 | PubTator's text mining | https://conductscience.org/library/genes/1084 | NCBI Gene |
| KRAS | 3,845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
| MAFB | 9,935 | PubTator's text mining | https://conductscience.org/library/genes/9935 | NCBI Gene |
| RUNX1 | 861 | PubTator's text mining | https://conductscience.org/library/genes/861 | NCBI Gene |
| RUNX1T1 | 862 | PubTator's text mining | https://conductscience.org/library/genes/862 | NCBI Gene |
| SMAD4 | 4,089 | PubTator's text mining | https://conductscience.org/library/genes/4089 | NCBI Gene |
| TP53 | 7,157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31533396
GET https://conductscience.org/api/papers/v1/31533396/references?page=2